Catch up on the top stories in optometry during the week of September 7-September 11.
Publication|Articles|June 20, 2024
- June digital edition 2024
- Volume 16
- Issue 06
Utilizing the immune system to combat dry eye disease
Author(s)Walter O. Whitley OD, MBA, FAAO
Exploring strategies for effective management of a multifaceted condition.
Advertisement
Advertisement
Dry eye disease (DED) is a chronic and often progressive condition that can be a source of frustration for patients and clinicians.1 Finding the right combination of treatments that effectively alleviate symptoms can be demanding, and the chronic nature of the condition typically requires ongoing management to maintain ocular health and comfort.
Related to this article
Catch up on the top stories in optometry during the week of August 31-September 4.
Acoltremon ophthalmic solution 0.003% usage was associated with improved performance in visual acuity tasks.
A recent study found that migraines were associated with higher adverse vision outcomes in a cohort of Norwegian adolescents.
Startup S5G Therapeutics aims to move ubiquinol technology from the laboratory toward treatments for dry eye, Fuchs dystrophy, and other corneal conditions.
Periocular skin treatment is emerging as a complementary treatment for dry eye disease.
The industry-sponsored survey reveals most women don't recognize dry eye as a symptom of perimenopause or menopause.
The evolution of IPL is not limited to its expanding role in ocular surface disease.
Advertisement
Advertisement